ArticleNPJ breast cancer2024

Pathologic complete response after neoadjuvant systemic therapy for breast cancer in BRCA mutation carriers and noncarriers.

Sara P Myers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.